Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Sebag-Montefiore

Showing results (21-30 of 52) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancerR Glynne-Jones, D Sebag-Montefiore, T S Maughan, et al.
The British Journal of Radiology|October 26, 2007
Omission of concurrent chemoradiation after a response to neoadjuvant chemotherapy in locally advanced rectal cancer with a synchronous liver metastasis: a note of cautionI Craven, J Haselden, K E Miller, et al.
The British Journal of Radiology|February 9, 2013
Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark caseS Gwynne, E Spezi, D Sebag-Montefiore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2020
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trialR Glynne-Jones, H M Meadows, A Lopes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resectionK Patel, D A Anthoney, A M Crellin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 17, 2012
The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancersM Lim, Z Hussain, A Howe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2021
The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal CancerF Slevin, C R Hanna, A Appelt, et al.
British Journal of Cancer|April 1, 2010
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)J Northover, R Glynne-Jones, D Sebag-Montefiore, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 20, 2015
The Effect of the UK Coordinating Centre for Cancer Research Anal Cancer Trial (ACT1) on Population-based Treatment and Survival for Squamous Cell Cancer of the AnusA Downing, E J A Morris, A Aravani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus controlR Glynne-Jones, N Counsell, P Quirke, et al.
Pageof 6

Showing results (21-30 of 52) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 15, 2005
A phase I dose escalation study of continuous oral capecitabine in combination with oxaliplatin and pelvic radiation (XELOX-RT) in patients with locally advanced rectal cancerR Glynne-Jones, D Sebag-Montefiore, T S Maughan, et al.
The British Journal of Radiology|October 26, 2007
Omission of concurrent chemoradiation after a response to neoadjuvant chemotherapy in locally advanced rectal cancer with a synchronous liver metastasis: a note of cautionI Craven, J Haselden, K E Miller, et al.
The British Journal of Radiology|February 9, 2013
Improving radiotherapy quality assurance in clinical trials: assessment of target volume delineation of the pre-accrual benchmark caseS Gwynne, E Spezi, D Sebag-Montefiore, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 4, 2020
Impact of compliance to chemoradiation on long-term outcomes in squamous cell carcinoma of the anus: results of a post hoc analysis from the randomised phase III ACT II trialR Glynne-Jones, H M Meadows, A Lopes, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 23, 2004
Weekly 5-fluorouracil and leucovorin: achieving lower toxicity with higher dose-intensity in adjuvant chemotherapy after colorectal cancer resectionK Patel, D A Anthoney, A M Crellin, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|October 17, 2012
The oncological outcome after right hemicolectomy and accuracy of CT scan as a preoperative tool for staging in right sided colonic cancersM Lim, Z Hussain, A Howe, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|December 27, 2021
The Long and the Short of it: the Role of Short-course Radiotherapy in the Neoadjuvant Management of Rectal CancerF Slevin, C R Hanna, A Appelt, et al.
British Journal of Cancer|April 1, 2010
Chemoradiation for the treatment of epidermoid anal cancer: 13-year follow-up of the first randomised UKCCCR Anal Cancer Trial (ACT I)J Northover, R Glynne-Jones, D Sebag-Montefiore, et al.
Clinical Oncology (Royal College of Radiologists (Great Britain))|July 20, 2015
The Effect of the UK Coordinating Centre for Cancer Research Anal Cancer Trial (ACT1) on Population-based Treatment and Survival for Squamous Cell Cancer of the AnusA Downing, E J A Morris, A Aravani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 11, 2014
Chronicle: results of a randomised phase III trial in locally advanced rectal cancer after neoadjuvant chemoradiation randomising postoperative adjuvant capecitabine plus oxaliplatin (XELOX) versus controlR Glynne-Jones, N Counsell, P Quirke, et al.
Pageof 6